Cryo Cell International (CCEL) Shares Outstanding (Diluted Average) (2010 - 2020)

Cryo Cell International (CCEL) has 7 years of Shares Outstanding (Diluted Average) data on file, last reported at $8.1 million in Q2 2020.

• Shares Outstanding (Diluted Average) for Q2 2020 came in at $8.1 million, down 3.68% year-over-year; the trailing twelve-month figure through May 2020 was $8.1 million (down 3.68% YoY), and the FY2019 annual result was $8.4 million, up 12.72% from the prior year.
• Shares Outstanding (Diluted Average) held at $8.1 million in Q2 2020 per CCEL's latest filing, from $8.1 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $8.4 million in Q3 2019 and troughed at $7.5 million in Q4 2018.
• A 3-year average of $8.2 million and a median of $8.4 million in 2018 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2019 and 2020: Shares Outstanding (Diluted Average) advanced 12.72% in 2019, then fell 3.68% in 2020.
• A 3-year view of Shares Outstanding (Diluted Average) shows it stood at $7.5 million in 2018, then increased by 12.72% to $8.4 million in 2019, then slipped by 3.57% to $8.1 million in 2020.
• Business Quant data shows CCEL's Shares Outstanding (Diluted Average) at $8.1 million in Q2 2020, $8.1 million in Q1 2020, and $8.4 million in Q4 2019.